Riskpilot← Back to searchSign inGet full accessMedincy Nordic AB
ABActiveOrg 5593941668Karbingatan 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20221 employees
Revenue 2025
SEK 1,6M
-22% vs 2024
EBITDA margin
-163.7%
-2% vs 2024
Equity ratio
-49.0%
Financial strength
Net profit 2025
SEK -2,6M
-1% vs 2024
| Revenue | SEK 1,6M | -22% |
| EBITDA | SEK -2,6M | -2% |
| Net profit | SEK -2,6M | -1% |
| Total assets | SEK 5,3M | -20% |
| Equity | SEK -2,6M | -10550% |
| Employees | 1 | — |
Legal name
Medincy Nordic AB
Org number
5593941668
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 augusti 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget bedriver handel med medicintekniska produkter samt konsulterande verksamhet inom medicinteknik och därmed förenlig verksamhet.
Address
Karbingatan 16
Email
info@medincy.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 96 | 2 061 | 1 599 |
| Staff expenses | — | — | −892 |
| EBITDA | −3 159 | −2 574 | −2 617 |
| Depreciation & amort. | −15 | −20 | −20 |
| EBIT | −3 174 | −2 594 | −2 637 |
| Net financials | −2 | −8 | −1 |
| Profit before tax | −3 175 | −2 601 | −2 638 |
| Tax | −0 | −0 | — |
| Net profit | −3 175 | −2 601 | −2 638 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 4 219 | 6 655 | 5 333 |
| Equity | −3 150 | 25 | −2 612 |
| Long-term debt | 6 944 | 6 432 | 7 388 |
| Short-term debt | 424 | 197 | 558 |
| Total debt | 7 368 | 6 629 | 7 946 |
EBITDA margin
-163.7%
This company
15.8%
Market median
-1136% vs market
20232025
Equity ratio
-49.0%
This company
38.2%
Market median
-228% vs market
20232025
Return on equity
-263754400.0%
This company
18.4%
Market median
-1433447926% vs market
20232025
Net profit margin
-165.0%
This company
8.1%
Market median
-2137% vs market
20232025
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20232025
Debt / equity
3.04×
This company
0.62×
Market median
-390% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SI | Audit | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Board of Directors | 2022 – 2025 | |
| Chairman | 2023 – 2023 | |
| Deputy Board Member | 2023 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medincy Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Inge Lennart Bergman | Audit | 0 companies |
| Egbert Adriaan Hengelmolen | Board of Directors | 0 companies |
| Karin Elisabet Jansson | Deputy Board Member | 0 companies |
| Anna Maria Winther | Chairman | 0 companies |
| Leopoldo Rodrigo Leiva Nykjær | Board of Directors | 0 companies |
| Pär Anders Öhman | Deputy Board Member | 0 companies |